YOLFTbeta
Ok Biotech Co Ltd

Ok Biotech Co Ltd

4155 · TW · Healthcare / Medical Devices

17.35TWD+0.65 (+3.89%)

Price History

Full chart

Market Stats

Previous Close16.70
Open16.90
Day Range16.90 – 18.30
52-Week Range12.85 – 16.50
Volume1.44M
Market Cap1.94B
P/E (TTM)8.63
Forward P/E0.00
EPS1.72
Dividend Yield0.00%
Beta0.24
50-Day Avg14.66
200-Day Avg14.43

About

OK Biotech Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of blood glucose monitoring systems and homecare healthcare devices in Taiwan, the rest of Asia, America, Africa, and Europe. The company offers nebulizers, blood glucose meters, glucometers, blood sugar meters, and blood glucose test strips. It also provides OTC hearing aids, multi-frequency therapy devices, and factory setup solutions, as well as professional OEM/ODM customized services. The company sells its products under the OKB and Prodigy brands. OK Biotech Co., Ltd. was incorporated in 2004 and is headquartered in Hsinchu City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Jia-De Lai
  • Employees0
  • HeadquartersNo. 91, Gongdao 5th Road, Hsinchu City, Taiwan, 30070, Taiwan
  • Websitehttps://www.okbiotech.com

Leadership

  • Mr. Jia-De LaiGeneral Manager, MD & Chairman of the Board
  • Qi Zheng HouCFO, Financial Manager & Accounting Supervisor
  • De Quan ZhangCOO & Deputy GM

Financials

Income Statement

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue280.79M405.99M502.54M656.70M1.07B633.76M856.55M1.04B1.23B1.12B1.24B1.48B1.26B1.48B1.19B1.67B1.56B
Growth (%)-+44.59%+23.78%+30.68%+63.59%-41.01%+35.15%+21.47%+18.51%-9.14%+10.79%+19.59%-14.89%+17.43%-19.65%+40.11%-6.81%
Cost of Revenue183.07M309.22M367.52M463.01M783.36M467.33M579.66M829.89M945.02M818.24M945.13M1.16B1.08B1.14B995.10M1.39B1.13B
Gross Profit97.72M96.77M135.01M193.68M290.92M166.43M276.89M210.57M288.05M302.11M296.13M325.95M186.83M344.96M196.88M275.65M429.25M
Gross Margin34.80%23.83%26.87%29.49%27.08%26.26%32.33%20.24%23.36%26.97%23.86%21.96%14.79%23.25%16.52%16.51%27.58%
Operating Expense34.91M48.83M59.92M83.46M149.83M127.97M163.64M102.57M157.47M160.39M148.65M155.86M137.51M133.33M208.95M218.44M321.36M
Operating Income62.82M47.93M75.09M110.22M141.09M38.46M113.25M108.00M130.58M141.72M147.47M170.10M49.31M211.62M-12.06M57.21M107.89M
Operating Margin22.37%11.81%14.94%16.78%13.13%6.07%13.22%10.38%10.59%12.65%11.88%11.46%3.90%14.26%-1.01%3.43%6.93%
EBITDA64.85M48.26M88.79M118.85M176.44M86.64M153.91M133.89M145.73M201.69M164.35M171.24M85.45M247.47M87.24M205.76M201.51M
EBITDA Margin23.10%11.89%17.67%18.10%16.42%13.67%17.97%12.87%11.82%18.00%13.24%11.54%6.76%16.68%7.32%12.32%12.95%
Net Income49.70M37.74M72.34M96.68M138.21M71.36M110.97M85.20M126.81M161.36M125.76M129.73M31.42M143.46M2.95M93.97M82.45M
Net Income Margin17.70%9.29%14.39%14.72%12.86%11.26%12.96%8.19%10.28%14.40%10.13%8.74%2.49%9.67%0.25%5.63%5.30%
R&D12.31M12.48M15.31M19.09M22.84M22.90M19.95M20.18M32.60M40.79M32.56M45.46M28.74M48.73M46.71M57.93M59.04M
R&D as % of Total Revenue4.38%3.07%3.05%2.91%2.13%3.61%2.33%1.94%2.64%3.64%2.62%3.06%2.27%3.28%3.92%3.47%3.79%
Interest Expense-691.00K308.00K139.00K5.92M9.03M6.34M3.58M4.02M5.30M6.12M8.12M8.08M11.42M9.00M6.23M10.92M
Interest Expense % of Total Revenue-0.17%0.06%0.02%0.55%1.42%0.74%0.34%0.33%0.47%0.49%0.55%0.64%0.77%0.75%0.37%0.70%

Balance Sheet

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets204.67M325.39M486.42M777.74M1.46B1.41B1.45B1.50B1.88B1.85B2.22B2.54B2.81B3.06B3.07B3.70B3.85B
Total Liabilities83.42M94.60M183.31M325.65M847.00M561.11M495.36M550.64M678.07M582.73M918.40M795.91M1.11B1.21B672.26M1.13B1.27B
Total Equity121.25M230.78M303.11M452.10M609.65M849.48M950.15M944.80M1.21B1.25B1.29B1.73B1.70B1.84B2.40B2.49B2.51B
Cash32.32M30.00M102.21M219.55M120.90M66.83M75.76M164.34M455.74M184.42M332.31M566.72M599.85M596.42M323.03M277.46M314.47M
Total Debt50.05M20.16M45.00M107.32M574.08M463.00M289.06M291.01M385.96M258.77M534.12M305.31M735.74M780.64M332.98M779.43M1.03B
Net Debt17.73M-9.85M-57.21M-112.23M453.18M396.17M213.29M126.66M-69.78M74.34M201.81M-261.41M135.88M184.22M9.94M501.97M719.51M

Cash Flow

Currency: TWD2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow6.95M-19.52M93.12M79.17M87.08M-33.83M289.44M260.72M102.77M128.75M45.18M147.70M21.90M240.53M2.93M65.90M319.57M
Investing Cash Flow-36.68M-68.78M-37.35M-103.77M-651.30M-55.26M-80.08M-67.61M-96.55M-62.18M-85.49M-126.96M-174.46M-294.23M-358.38M-444.93M-398.50M
Financing Cash Flow30.00M85.97M16.44M141.93M465.56M34.60M-200.25M-104.11M285.16M-337.91M185.07M215.81M185.69M50.27M82.06M338.02M113.04M
Capital Expenditure35.06M68.15M36.99M88.53M202.91M5.68M86.46M56.99M88.04M28.36M77.95M79.79M86.46M294.24M437.08M374.72M409.14M
Free Cash Flow-28.11M-87.67M56.12M-9.36M-115.82M-39.52M202.97M203.73M14.73M100.39M-32.78M67.91M-64.57M-53.72M-434.15M-308.81M-89.57M
Dividends Paid-4.73M8.56M30.11M10.14M15.96M10.61M100.18M100.43M111.34M166.39M112.14M131.85M94.93M144.64M44.12M43.79M
FCF to OCF-404.49%449.23%60.27%-11.82%-133.00%116.80%70.13%78.14%14.33%77.97%-72.55%45.98%-294.88%-22.33%-14802.11%-468.59%-28.03%
Dividend Paid to FCF--5.40%15.25%-321.71%-8.76%-40.38%5.23%49.17%681.83%110.91%-507.62%165.13%-204.21%-176.74%-33.32%-14.29%-48.89%

Earnings

Report DateMar 31, 2012Jun 30, 2012Dec 31, 2012Mar 31, 2017Aug 30, 2017Nov 10, 2017Mar 14, 2018May 14, 2018Aug 13, 2018Nov 13, 2018Mar 27, 2019May 14, 2019Aug 14, 2019Nov 13, 2019Mar 24, 2020May 13, 2020Aug 12, 2020Nov 12, 2020Mar 31, 2021May 12, 2021Aug 15, 2021Nov 11, 2021Mar 9, 2022May 11, 2022Aug 10, 2022Nov 9, 2022Mar 9, 2023May 11, 2023
EPS Estimate-------------0.400.520.490.520.350.640.290.25-------
EPS Actual0.480.441.820.390.490.580.360.540.370.620.530.380.330.430.430.520.230.260.320.300.230.15-0.010.440.520.43-0.060.16
Surprise-------------7.50%-17.31%6.12%-55.77%-25.71%-50.00%3.45%-8.00%-------
Timing-----Pre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hours

Key Statistics & Ratios

Market Cap1.94B
Enterprise Value2.37B
Trailing P/E8.63
Forward P/E0.00
Price / Sales1.26
Price / Book0.68
EPS1.72
Book Value18.35
Revenue (TTM)1.54B
Gross Profit (TTM)478.56M
EBITDA300.14M
Profit Margin15.76%
Operating Margin11.85%
Return on Equity10.29%
Return on Assets3.59%
Shares Outstanding130.72M
Shares Float97.39M
Beta0.24
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20261×
0.30Oct 20, 2026
20251×
0.30Jul 4, 2025
20241×
0.30Sep 5, 2024
20231×
1.23Sep 6, 2023
20221×
0.89Jul 6, 2022
20211×
1.23Jul 12, 2021
20201×
1.27Jun 22, 2020
20191×
1.95Jun 27, 2019
20181×
1.28Jul 2, 2018
20171×
0.95Jun 21, 2017
20161×
1.30Jul 18, 2016
20152×
0.17Sep 30, 20150.20Sep 29, 2015
20141×
0.23Jul 21, 2014
20131×
0.23Jul 29, 2013

Stock Splits

  • Sep 6, 20231102.1342:1000
  • Jul 2, 20181030:1000
  • Sep 30, 20151202.406:1000
  • Jul 21, 20141300:1000
  • Jul 29, 20131.3:1